Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Defining the dynamic chromatin landscape of mouse nephron progenitors.

Hilliard S, Song R, Liu H, Chen CH, Li Y, Baddoo M, Flemington E, Wanek A, Kolls J, Saifudeen Z, El-Dahr SS.

Biol Open. 2019 May 20;8(5). pii: bio042754. doi: 10.1242/bio.042754.

2.

DNA methylation links intrauterine stress with abnormal nephrogenesis.

El-Dahr SS.

Nat Rev Nephrol. 2019 Apr;15(4):196-197. doi: 10.1038/s41581-019-0114-y. No abstract available.

PMID:
30670870
3.

Epigenetic regulation of renal development.

El-Dahr SS, Saifudeen Z.

Semin Cell Dev Biol. 2019 Jul;91:111-118. doi: 10.1016/j.semcdb.2018.08.014. Epub 2018 Sep 5. Review.

PMID:
30172047
4.

Histone deacetylases 1 and 2 regulate the transcriptional programs of nephron progenitors and renal vesicles.

Liu H, Chen S, Yao X, Li Y, Chen CH, Liu J, Saifudeen Z, El-Dahr SS.

Development. 2018 May 18;145(10). pii: dev153619. doi: 10.1242/dev.153619.

5.

p63+ ureteric bud tip cells are progenitors of intercalated cells.

El-Dahr SS, Li Y, Liu J, Gutierrez E, Hering-Smith KS, Signoretti S, Pignon JC, Sinha S, Saifudeen Z.

JCI Insight. 2017 May 4;2(9). pii: 89996. doi: 10.1172/jci.insight.89996. eCollection 2017 May 4.

6.

Bradykinin/B2 receptor activation regulates renin in M-1 cells via protein kinase C and nitric oxide.

Lara LS, Bourgeois CR, El-Dahr SS, Prieto MC.

Physiol Rep. 2017 Apr;5(7). pii: e13211. doi: 10.14814/phy2.13211.

7.

Epigenetics of Renal Development and Disease.

Hilliard SA, El-Dahr SS.

Yale J Biol Med. 2016 Dec 23;89(4):565-573. eCollection 2016 Dec. Review.

8.

Epigenetics mechanisms in renal development.

Hilliard SA, El-Dahr SS.

Pediatr Nephrol. 2016 Jul;31(7):1055-60. doi: 10.1007/s00467-015-3228-x. Epub 2015 Oct 22. Review.

9.

Conditional knockout of collecting duct bradykinin B2 receptors exacerbates angiotensin II-induced hypertension during high salt intake.

Kopkan L, Husková Z, Jíchová Š, Červenková L, Červenka L, Saifudeen Z, El-Dahr SS.

Clin Exp Hypertens. 2016;38(1):1-9. doi: 10.3109/10641963.2015.1047945. Epub 2015 Jul 7.

10.

Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium.

Chen S, Yao X, Li Y, Saifudeen Z, Bachvarov D, El-Dahr SS.

Development. 2015 Mar 15;142(6):1180-92. doi: 10.1242/dev.113506.

11.

Epigenetic States of nephron progenitors and epithelial differentiation.

Adli M, Parlak M, Li Y, El-Dahr SS.

J Cell Biochem. 2015 Jun;116(6):893-902. doi: 10.1002/jcb.25048. Review.

12.

Elevated expression of long intergenic non-coding RNA HOTAIR in a basal-like variant of MCF-7 breast cancer cells.

Zhuang Y, Nguyen HT, Burow ME, Zhuo Y, El-Dahr SS, Yao X, Cao S, Flemington EK, Nephew KP, Fang F, Collins-Burow B, Rhodes LV, Yu Q, Jayawickramarajah J, Shan B.

Mol Carcinog. 2015 Dec;54(12):1656-67. doi: 10.1002/mc.22237. Epub 2014 Oct 18.

13.

Genome-wide analysis of gestational gene-environment interactions in the developing kidney.

Yan L, Yao X, Bachvarov D, Saifudeen Z, El-Dahr SS.

Physiol Genomics. 2014 Sep 1;46(17):655-70. doi: 10.1152/physiolgenomics.00035.2014. Epub 2014 Jul 8.

14.

Mdm2 is required for maintenance of the nephrogenic niche.

Hilliard SA, Yao X, El-Dahr SS.

Dev Biol. 2014 Mar 1;387(1):1-14. doi: 10.1016/j.ydbio.2014.01.009. Epub 2014 Jan 17.

15.

In situ histone landscape of nephrogenesis.

McLaughlin N, Wang F, Saifudeen Z, El-Dahr SS.

Epigenetics. 2014 Feb;9(2):222-35. doi: 10.4161/epi.26793. Epub 2013 Oct 29.

16.

Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidney.

Li Y, Liu J, McLaughlin N, Bachvarov D, Saifudeen Z, El-Dahr SS.

Physiol Genomics. 2013 Oct 16;45(20):948-64. doi: 10.1152/physiolgenomics.00113.2013. Epub 2013 Sep 3.

17.

Histone signature of metanephric mesenchyme cell lines.

McLaughlin N, Yao X, Li Y, Saifudeen Z, El-Dahr SS.

Epigenetics. 2013 Sep;8(9):970-8. doi: 10.4161/epi.25753. Epub 2013 Jul 18.

18.

Interactions between BdkrB2 and p53 genes in the developing kidney.

El-Dahr SS, Saifudeen Z.

Biol Chem. 2013 Mar;394(3):347-51. doi: 10.1515/hsz-2012-0281. Review.

PMID:
23152407
19.

A p53-Pax2 pathway in kidney development: implications for nephrogenesis.

Saifudeen Z, Liu J, Dipp S, Yao X, Li Y, McLaughlin N, Aboudehen K, El-Dahr SS.

PLoS One. 2012;7(9):e44869. doi: 10.1371/journal.pone.0044869. Epub 2012 Sep 12.

20.

Histone deacetylases in kidney development: implications for disease and therapy.

Chen S, El-Dahr SS.

Pediatr Nephrol. 2013 May;28(5):689-98. doi: 10.1007/s00467-012-2223-8. Epub 2012 Jun 22. Review.

PMID:
22722820
21.

Angiotensin II regulates growth of the developing papillas ex vivo.

Song R, Preston G, Khalili A, El-Dahr SS, Yosypiv IV.

Am J Physiol Renal Physiol. 2012 May 1;302(9):F1112-20. doi: 10.1152/ajprenal.00435.2011. Epub 2012 Feb 1.

22.

Mechanisms of p53 activation and physiological relevance in the developing kidney.

Aboudehen K, Hilliard S, Saifudeen Z, El-Dahr SS.

Am J Physiol Renal Physiol. 2012 Apr 15;302(8):F928-40. doi: 10.1152/ajprenal.00642.2011. Epub 2012 Jan 11.

23.

Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation.

Chen S, Bellew C, Yao X, Stefkova J, Dipp S, Saifudeen Z, Bachvarov D, El-Dahr SS.

J Biol Chem. 2011 Sep 16;286(37):32775-89. doi: 10.1074/jbc.M111.248278. Epub 2011 Jul 21.

24.

Atypical hemolytic-uremic syndrome in a child presenting with malignant hypertension.

Totina A, Iorember F, El-Dahr SS, Yosypiv IV.

Clin Pediatr (Phila). 2013 Feb;52(2):183-6. doi: 10.1177/0009922811412942. Epub 2011 Jun 27. No abstract available.

PMID:
21708810
25.

Receptor tyrosine kinases in kidney development.

Song R, El-Dahr SS, Yosypiv IV.

J Signal Transduct. 2011;2011:869281. doi: 10.1155/2011/869281. Epub 2011 Mar 3.

26.

Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching.

Hilliard S, Aboudehen K, Yao X, El-Dahr SS.

Dev Biol. 2011 May 15;353(2):354-66. doi: 10.1016/j.ydbio.2011.03.017. Epub 2011 Mar 21.

27.

Regulation of kidney development by histone deacetylases.

Rosenberg SL, Chen S, McLaughlin N, El-Dahr SS.

Pediatr Nephrol. 2011 Sep;26(9):1445-52. doi: 10.1007/s00467-011-1796-y. Epub 2011 Feb 19. Review.

28.

A child with Wegener's granulomatosis and severe hemophilia A: interplay of disease processes.

Pandey AC, Yosypiv IV, Kanter J, Scher CD, Davis SH, El-Dahr SS.

Clin Pediatr (Phila). 2011 Aug;50(8):767-71. doi: 10.1177/0009922810384261. Epub 2010 Nov 22. No abstract available.

PMID:
21098530
29.

Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter.

van Bodegom D, Roessingh W, Pridjian A, El Dahr SS.

Biochim Biophys Acta. 2010 Jul;1799(7):502-9. doi: 10.1016/j.bbagrm.2010.04.001. Epub 2010 Apr 11.

30.

A novel bioassay for detecting GPCR heterodimerization: transactivation of beta 2 adrenergic receptor by bradykinin receptor.

Haack KK, Tougas MR, Jones KT, El-Dahr SS, Radhakrishna H, McCarty NA.

J Biomol Screen. 2010 Mar;15(3):251-60. doi: 10.1177/1087057109360254. Epub 2010 Feb 11.

PMID:
20150590
31.

Angiotensin II AT2 receptor regulates ureteric bud morphogenesis.

Song R, Spera M, Garrett C, El-Dahr SS, Yosypiv IV.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F807-17. doi: 10.1152/ajprenal.00147.2009. Epub 2009 Dec 23.

32.

p53 regulates metanephric development.

Saifudeen Z, Dipp S, Stefkova J, Yao X, Lookabaugh S, El-Dahr SS.

J Am Soc Nephrol. 2009 Nov;20(11):2328-37. doi: 10.1681/ASN.2008121224. Epub 2009 Sep 3.

33.

Bradykinin B2 receptor null mice harboring a Ser23-to-Ala substitution in the p53 gene are protected from renal dysgenesis.

El-Dahr SS, Aboudehen K, Dipp S.

Am J Physiol Renal Physiol. 2008 Nov;295(5):F1404-13. doi: 10.1152/ajprenal.90378.2008. Epub 2008 Aug 27.

34.

Downregulation of Spry-1, an inhibitor of GDNF/Ret, causes angiotensin II-induced ureteric bud branching.

Yosypiv IV, Boh MK, Spera MA, El-Dahr SS.

Kidney Int. 2008 Nov;74(10):1287-93. doi: 10.1038/ki.2008.378. Epub 2008 Jul 23.

35.

Transcriptional control of terminal nephron differentiation.

El-Dahr SS, Aboudehen K, Saifudeen Z.

Am J Physiol Renal Physiol. 2008 Jun;294(6):F1273-8. doi: 10.1152/ajprenal.00562.2007. Epub 2008 Feb 20. Review.

36.

The Bradykinin B2 receptor gene is a target of angiotensin II type 1 receptor signaling.

Shen B, Harrison-Bernard LM, Fuller AJ, Vanderpool V, Saifudeen Z, El-Dahr SS.

J Am Soc Nephrol. 2007 Apr;18(4):1140-9. Epub 2007 Mar 7.

37.

The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repression.

Van Bodegom D, Saifudeen Z, Dipp S, Puri S, Magenheimer BS, Calvet JP, El-Dahr SS.

J Biol Chem. 2006 Oct 20;281(42):31234-44. Epub 2006 Aug 24.

38.

Susceptibility to metanephric apoptosis in bradykinin B2 receptor null mice via the p53-Bax pathway.

Fan H, Stefkova J, El-Dahr SS.

Am J Physiol Renal Physiol. 2006 Sep;291(3):F670-82. Epub 2006 Mar 28.

39.

Cross-talk of the renin-angiotensin and kallikrein-kinin systems.

Shen B, El-Dahr SS.

Biol Chem. 2006 Feb;387(2):145-50. Review.

PMID:
16497145
40.

Angiotensin II type 1 receptor-EGF receptor cross-talk regulates ureteric bud branching morphogenesis.

Yosypiv IV, Schroeder M, El-Dahr SS.

J Am Soc Nephrol. 2006 Apr;17(4):1005-14. Epub 2006 Feb 22.

41.

Role of the renin-angiotensin system in the development of the ureteric bud and renal collecting system.

Yosypiv IV, El-Dahr SS.

Pediatr Nephrol. 2005 Sep;20(9):1219-29. Epub 2005 Jun 8. Review.

PMID:
15942783
42.

Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.

Saifudeen Z, Diavolitsis V, Stefkova J, Dipp S, Fan H, El-Dahr SS.

J Biol Chem. 2005 Jun 17;280(24):23094-102. Epub 2005 Apr 1.

43.

Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation.

Saifudeen Z, Dipp S, Fan H, El-Dahr SS.

Am J Physiol Renal Physiol. 2005 May;288(5):F899-909. Epub 2005 Jan 4.

44.

A novel pathological role of p53 in kidney development revealed by gene-environment interactions.

Fan H, Harrell JR, Dipp S, Saifudeen Z, El-Dahr SS.

Am J Physiol Renal Physiol. 2005 Jan;288(1):F98-107. Epub 2004 Sep 21.

45.

Spatial expression of the kallikrein-kinin system during nephrogenesis.

El-Dahr SS.

Histol Histopathol. 2004 Oct;19(4):1301-10. doi: 10.14670/HH-19.1301. Review.

PMID:
15375773
46.

The Bradykinin B2 receptor is required for full expression of renal COX-2 and renin.

Imig JD, Zhao X, Orengo SR, Dipp S, El-Dahr SS.

Peptides. 2003 Aug;24(8):1141-7.

PMID:
14612184
47.

Genetic inactivation of the B2 receptor in mice worsens two-kidney, one-clip hypertension: role of NO and the AT2 receptor.

Cervenka L, Vanecková I, Malý J, Horácek V, El-Dahr SS.

J Hypertens. 2003 Aug;21(8):1531-8.

PMID:
12872048
48.

Renal and blood pressure phenotype in 18-mo-old bradykinin B2R(-/-)CRD mice.

Harrison-Bernard LM, Dipp S, El-Dahr SS.

Am J Physiol Regul Integr Comp Physiol. 2003 Oct;285(4):R782-90. Epub 2003 Jun 12.

49.

Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter.

Marks J, Saifudeen Z, Dipp S, El-Dahr SS.

J Biol Chem. 2003 Sep 5;278(36):34158-66. Epub 2003 Jun 5.

50.

Spatial repression of PCNA by p53 during kidney development.

Saifudeen Z, Marks J, Du H, El-Dahr SS.

Am J Physiol Renal Physiol. 2002 Oct;283(4):F727-33.

Supplemental Content

Loading ...
Support Center